JP2024520788A5 - - Google Patents
Info
- Publication number
- JP2024520788A5 JP2024520788A5 JP2023575713A JP2023575713A JP2024520788A5 JP 2024520788 A5 JP2024520788 A5 JP 2024520788A5 JP 2023575713 A JP2023575713 A JP 2023575713A JP 2023575713 A JP2023575713 A JP 2023575713A JP 2024520788 A5 JP2024520788 A5 JP 2024520788A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- aqueous solution
- subject
- bumetanide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163208863P | 2021-06-09 | 2021-06-09 | |
| US63/208,863 | 2021-06-09 | ||
| PCT/US2022/032862 WO2022261344A1 (en) | 2021-06-09 | 2022-06-09 | Subcutaneous formulation and methods for treating edema refractory to oral diuretics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520788A JP2024520788A (ja) | 2024-05-24 |
| JP2024520788A5 true JP2024520788A5 (https=) | 2025-06-16 |
Family
ID=84425561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023575713A Pending JP2024520788A (ja) | 2021-06-09 | 2022-06-09 | 経口利尿薬に不応性の浮腫を処置するための皮下製剤及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240285566A1 (https=) |
| EP (1) | EP4351554A4 (https=) |
| JP (1) | JP2024520788A (https=) |
| KR (1) | KR20240042402A (https=) |
| CN (1) | CN117915905A (https=) |
| AU (1) | AU2022289724A1 (https=) |
| BR (1) | BR112023025880A2 (https=) |
| CA (1) | CA3221710A1 (https=) |
| IL (1) | IL309160A (https=) |
| WO (1) | WO2022261344A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL293429A (en) | 2019-12-04 | 2022-07-01 | RESQ Pharmaceuticals LLC | Methods and preparations for the treatment of edema resistant to oral diuretics |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040105818A1 (en) * | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
| US7906555B2 (en) * | 2006-10-26 | 2011-03-15 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance |
| US20140128469A1 (en) * | 2011-05-10 | 2014-05-08 | Concert Pharmaceuticals Inc. | Deuterated n-butyl bumetanide |
| US20210163406A1 (en) * | 2018-04-06 | 2021-06-03 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Bumetanide Derivatives for the Therapy of Stroke and Other Neurological Diseases/Disorders Involving NKCCs |
| IL293429A (en) * | 2019-12-04 | 2022-07-01 | RESQ Pharmaceuticals LLC | Methods and preparations for the treatment of edema resistant to oral diuretics |
-
2022
- 2022-06-09 JP JP2023575713A patent/JP2024520788A/ja active Pending
- 2022-06-09 EP EP22821041.5A patent/EP4351554A4/en active Pending
- 2022-06-09 CA CA3221710A patent/CA3221710A1/en active Pending
- 2022-06-09 IL IL309160A patent/IL309160A/en unknown
- 2022-06-09 KR KR1020247000323A patent/KR20240042402A/ko active Pending
- 2022-06-09 BR BR112023025880A patent/BR112023025880A2/pt not_active Application Discontinuation
- 2022-06-09 CN CN202280053609.8A patent/CN117915905A/zh active Pending
- 2022-06-09 AU AU2022289724A patent/AU2022289724A1/en active Pending
- 2022-06-09 US US18/568,440 patent/US20240285566A1/en active Pending
- 2022-06-09 WO PCT/US2022/032862 patent/WO2022261344A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230112834A1 (en) | Parenteral formulations of treprostinil | |
| KR950013452B1 (ko) | 세포 및 조직 수복제 | |
| JP2023505189A5 (https=) | ||
| EP1696932B1 (en) | Use of treprostinil to improve kidney functions | |
| JP2023002662A5 (https=) | ||
| JPH013193A (ja) | 細胞、組織修復剤 | |
| JP2023088944A5 (https=) | ||
| US20050282903A1 (en) | Use of Treprostinil to treat neuropathic diabetic foot ulcers | |
| RU2013108857A (ru) | Соединения для лечения/профилактики воспалительных глазных заболевний | |
| RU2488393C2 (ru) | Жидкие композиции, включающие валсартан | |
| JP2711759B2 (ja) | 止瀉剤組成物 | |
| US4789660A (en) | Insulin administration using methyl and propyl paraben | |
| Ashchi et al. | Cardiac complication from use of cocaine and phenylephrine in nasal septoplasty | |
| EP2782564B1 (en) | Cysteamine and/or cystamine for treating ischemic injury | |
| Bergeron et al. | Myocardial infarction, severe reversible ischemia, and shock following excess thyroid administration in a woman with normal coronary arteries | |
| JP2590156B2 (ja) | 経口投与用医薬組成物 | |
| JP2024520788A5 (https=) | ||
| BG65818B1 (bg) | Циклесонид-съдържащ фармацевтичен състав за прилагане върху мукоза | |
| US3621094A (en) | Concentrated aqueous liquid antacid compositions containing certain phosphate and gluconate salts | |
| JP2024532957A5 (https=) | ||
| JP2023520703A5 (https=) | ||
| ES2252751T3 (es) | Medicamento para el corazon pulmonar. | |
| WO2023185911A1 (zh) | 一种吡啶磺酰胺磷酸酯类化合物在制备抗脑水肿药物中的用途 | |
| Lunder et al. | SGLT-2 inhibitors: a novelty in the treatment of type 2 diabetes | |
| JPS5846023A (ja) | ヒトプロインシユリン製剤 |